News
The following is a summary of “Factors associated with worsening interstitial fibrosis/tubular atrophy in lupus nephritis ...
The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback